Omron Healthcare, Inc. Finalizes U.S. Acquisition of Colin Medical Instruments

Omron Healthcare, Inc. Finalizes U.S. Acquisition of Colin Medical Instruments Corporation

Acquisition Integrates Medical Workplaces with Patient Homes

Bannockburn, Ill. – April 3, 2006 – Omron Healthcare, Inc. today announced the completion of the acquisition of San Antonio-based Colin Medical Instruments Corporation (CMI). The announcement follows Omron Healthcare Co. Ltd.'s ( Kyoto , Japan ) acquisition of Colin Medical Technology Corporation ( Komaki , Japan ) in June 2005.

“The acquisition of CMI enables Omron Healthcare to become a unique company providing a wide range of product offerings in medical devices for use in hospitals and in the home,” said Isao Ogino, CEO of Omron Healthcare, Inc. “By addressing the needs of the medical professional and the consumer, Omron Healthcare is providing comprehensive healthcare solutions to all sites of care.”

While CMI's production function will continue, through this acquisition, CMI's sales and marketing functions will be transitioned to Omron Healthcare. Colin ? products include vital signs monitors, inpatient blood pressure monitoring devices and vascular screening devices – all used in the professional setting. Omron Healthcare's home healthcare products, include Omron ? brand blood pressure monitors, respiratory, weight management and thermometry products.

As the number of Americans with lifestyle-related diseases such as hypertension and diabetes continues to increase, the need for comprehensive healthcare solutions is greater than ever before.

New areas of focus that will be created by this acquisition will include:

Enabling clinicians to assess arterial stiffness through products utilizing Colin and Omron Healthcare technologies;

Identifying opportunities to connect the consumer and the clinician for more effective healthcare management.

Omron Healthcare's acquisition is also intended to enrich its current business by:

Expanding its blood pressure monitoring business;

Continuing to strengthen its brand by promoting its blood pressure monitoring technology and products for the medical workplace (hospitals and clinics) and home use;

Developing the next generation of blood pressure monitoring technology; and

Enhancing the availability CMI's products in the North and South American market.